← Back to Search

Other

MP-101 for Obesity

Phase 2
Waitlist Available
Research Sponsored by Manhattan Pharmaceuticals
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Subject is obese as defined as a BMI of 40 - 55.
Subject is a male and is between 18-60 years of age.
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 years
Awards & highlights

Study Summary

This trial is testing the safety and effectiveness of two different doses of MP-101, compared to placebo, in obese people.

Who is the study for?
This trial is for male adults aged 18-60 with severe obesity (BMI of 40 - 55) who have stable weight, exercise, and smoking habits. They must be in reasonable health without a recent history of dieting or investigational meds. Participants need to understand English and commit to the study schedule.Check my eligibility
What is being tested?
The study tests Oleoyl-Estrone at two doses (10 mg and 30 mg) compared to a placebo. It's conducted across multiple centers where men will take the assigned treatment orally once daily for 30 days to see its effects on obesity.See study design
What are the potential side effects?
Potential side effects are not specified here but typically may include digestive issues, changes in appetite or metabolism, fatigue, mood swings, and possibly hormonal imbalances due to the nature of the compound being tested.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
My BMI is between 40 and 55, classifying me as obese.
Select...
I am a man aged between 18 and 60.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 5 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
To evaluate the safety and tolerability
Secondary outcome measures
To evaluate the preliminary efficacy

Find a Location

Who is running the clinical trial?

Manhattan PharmaceuticalsLead Sponsor
2 Previous Clinical Trials
161 Total Patients Enrolled
1 Trials studying Obesity
100 Patients Enrolled for Obesity

Media Library

Oleoyl-Estrone (Other) Clinical Trial Eligibility Overview. Trial Name: NCT00449254 — Phase 2
Obesity Research Study Groups:
Obesity Clinical Trial 2023: Oleoyl-Estrone Highlights & Side Effects. Trial Name: NCT00449254 — Phase 2
Oleoyl-Estrone (Other) 2023 Treatment Timeline for Medical Study. Trial Name: NCT00449254 — Phase 2
Obesity Patient Testimony for trial: Trial Name: NCT00449254 — Phase 2

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Who meets the necessary requirements to join this clinical trial?

"Eligible individuals for this trial must be obese, between 18-60 years old, and willing to enroll with around 24 other patients."

Answered by AI

If a patient is over the age of 84, can they still qualify for this experiment?

"The age requirements to participate in this study are that you must be an adult, over 18 years old, and younger than 60."

Answered by AI

Are participants still being recruited for this research project?

"According to the website clinicaltrials.gov, this study is not currently recruiting patients. This trial was posted on October 1st 2006 and was last edited June 4th 2007. Although this particular trial has ended, there are 999 other trials that are still looking for candidates."

Answered by AI

What is the FDA's stance on this medication?

"This treatment's safety rating is a 2. While there have been Phase 2 trials assessing the safety of this medication, there is currently no evidence to support its efficacy."

Answered by AI

Who else is applying?

What state do they live in?
New York
Texas
How old are they?
18 - 65
What site did they apply to?
St. Luke's-Roosevelt Hospital
Jean Brown Research
Research Across America
What portion of applicants met pre-screening criteria?
Met criteria
How many prior treatments have patients received?
0
1

Why did patients apply to this trial?

What does the trial pay. Seeking help with obesity.
PatientReceived 1 prior treatment
~1 spots leftby Apr 2025